---
schema_version: "secwatch.filing_event.v1"
accession: "0001651308-26-000020"
form_type: "8-K"
ticker: "ONC"
cik: "0001651308"
company_name: "BeOne Medicines Ltd."
filed_at: "2026-06-26T10:02:23+00:00"
generated_at: "2026-06-26T10:10:13.763520+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# BeOne Medicines settles China tax audit; pays ~RMB 446M in Q2 2026

## Summary
- Settled statutory tax audit in China; payment of approx. RMB 446 million (including surcharges and interest) to be recognized in Q2 2026.
- No administrative penalty imposed; adjustments to previously filed tax returns agreed with local tax authority.
- The payment resolves an uncertain tax position previously disclosed in the Q1 2026 10-Q filing.
- Approximate USD equivalent ~$62M based on current exchange rates; cash flow impact in 2Q 2026.

## SEC filing metadata
- accession: 0001651308-26-000020
- form_type: 8-K
- ticker: ONC
- cik: 0001651308
- company_name: BeOne Medicines Ltd.
- filed_at: 2026-06-26T10:02:23+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1651308/000165130826000020/0001651308-26-000020-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1651308/000165130826000020/bgne-20260626.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001651308-26-000020
- JSON: https://secwatch.observer/filing/0001651308-26-000020.json
- Plain text: https://secwatch.observer/filing/0001651308-26-000020.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.